Understanding Pharmacokinetic-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2024 to Better Manage the Risk of Drug Interactions With Concomitant Medications: A Review of Clinical Data From New Drug Applications

Objective: This analysis aimed to provide a mechanistic understanding and an evaluation of the clinical relevance of pharmacokinetic drug-drug interactions (DDIs) associated with drugs approved by the Food and Drug Administration in 2024. Methods: Drug metabolism, transport, and absorption-based DDI...

Full description

Bibliographic Details
Published in:Current Therapeutic Research
Main Authors: Jingjing Yu, MD, PhD, Sophie Argon, PharmD, Katie Owens, BPharm, PhD, Yan Wang, MS, Isabelle Ragueneau-Majlessi, MD, MS
Format: Article
Language:English
Published: Elsevier 2026-06-01
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0011393X25000438